Immunsys is a groundbreaking brand that offers a breakthrough therapy called YourVaccx™ for metastatic solid tumor cancers. This therapy revolutionizes the immune system's capability to combat cancer that has spread throughout the body. YourVaccx™ enables the patient's immune system to develop a personalized in-situ autologous vaccine, targeting cancer cells throughout the entire body.

The process involves controlled cellular lysis of a tumor segment, which releases tumor antigens and other molecules that activate the immune system. A specialized immunotherapy drug is then locally injected, providing both checkpoint blockade and immune stimulation. This combination approach empowers the immune system to create an in-situ autologous vaccine, resulting in an abscopal effect that attacks the metastatic cancer throughout the body.

Immunsys takes a revolutionary approach by enhancing the immune system's abilities in fighting metastatic solid tumor cancers. Contact Immunsys to learn more about this innovative therapy and its potential in cancer treatment